trial

Acceptance and Commitment Therapy for Delusions

NCTId NCT00657631

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

— · Completed

Enrollment 4 (actual)

Sponsored by Weill Medical College of Cornell University

Primary completion 2009-06

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

4 (actual)

Study type

Interventional

Allocation

Randomized

Model

Single Group

Masking

Single

Start

2008-04

Primary completion

2009-06

Eligibility

ALL · 18 Years · 65 Years

Interventions & indications

Drugs

Acceptance and Commitment Therapy

Indications

Schizophrenia, Paranoid Schizophrenia Delusions Schizophrenia Delusional Disorder

Investigators

Yulia Landa, Psy D.Principal Investigator

Sites

1 total

New York, United States

Facts & assertions

4 sourced

Enrollment

Phase

Primary Completion Date

2009-06

Status

COMPLETED

relationships

The graph out of here

drug

Acceptance and Commitment Therapy

drug

lead_sponsor

Weill Medical College of Cornell University

company

indication

Schizophrenia, Paranoid

indication

Schizophrenia

indication

Delusions

indication

investigator

Yulia Landa, Psy D.

person